论文部分内容阅读
目的观察乳果糖口服液联合便通胶囊治疗小儿脾肾虚弱型功能性便秘的临床疗效。方法选取2013年6月至2015年12月在我院门诊及住院部确诊的患儿60例,随机分为对照组和治疗组,各30例。对照组给予乳果糖口服液,治疗组在对照组治疗方法的基础上加服便通胶囊,2组均连续治疗2周后统计疗效。结果治疗组总有效率为90.00%,对照组为76.67%,2组总有效率比较差异有统计意义(P<0.05);治疗后治疗组患儿大便费力、艰涩不畅、便意未尽、腹胀腹痛等临床症状的消失率均高于对照组,差异均有统计意义(P<0.05);且治疗组患儿每周大便次数明显多于对照组,大便恢复正常时间和腹痛次数明显低于对照组,差异均有统计意义(P<0.05)。结论乳果糖口服液联合便通胶囊治疗小儿脾肾虚弱型功能性便秘疗效确切,值得临床推广。
Objective To observe the clinical efficacy of Lactulose oral solution combined with Tongtong capsule in the treatment of children with spleen and kidney weak functional constipation. Methods Sixty children diagnosed in outpatient department and inpatient department of our hospital from June 2013 to December 2015 were randomly divided into control group and treatment group, with 30 cases in each group. Control group was given lactulose oral solution, the treatment group in the control group on the basis of treatment plus service capsule, two groups were continuous treatment for 2 weeks after the statistical effect. Results The total effective rate was 90.00% in the treatment group and 76.67% in the control group, and the total effective rate in the two groups was statistically significant (P <0.05). After treatment, the stools in the treatment group were laborious, difficult and unsmooth, Abdominal pain and other clinical symptoms were higher than the disappearance rate of the control group, the difference was statistically significant (P <0.05); and the treatment group of children stool frequency significantly more than the control group, stool recovery time and abdominal pain were significantly lower than the control Group, the differences were statistically significant (P <0.05). Conclusion Lactulose oral solution combined with convenient capsule for children with spleen and kidney weak functional constipation curative effect is worthy of clinical promotion.